Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
8.05
+0.17 (+2.16%)
Range 7.92 - 8.10
Open 7.92
Prev Close 7.88
52 Week 5.60 - 12.46
Volume 491504
Market Cap 834.08M
*Delayed 6/30/2015 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000